At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to supplying cutting-edge chemical compounds that drive scientific discovery and therapeutic innovation. Nastorazepide (Z-360) stands out as a particularly promising molecule due to its potent and selective antagonism of the CCK-2 receptor. This receptor plays a significant role in various physiological processes and has been implicated in the pathogenesis of several diseases, making Nastorazepide a subject of intense research.

The core of Nastorazepide's utility lies in its ability to block the activity of the CCK-2 receptor. This is crucial because the CCK-2 receptor is often overexpressed in tumor cells, including those of pancreatic cancer, contributing to their growth and survival. By antagonizing this receptor, Nastorazepide effectively interrupts signaling cascades that fuel cancer progression. This targeted action makes it a valuable tool for researchers investigating new cancer therapies. The specific mechanism of action involves preventing gastrin, a key ligand for the CCK-2 receptor, from binding and activating the receptor, thereby mitigating downstream effects that promote tumor proliferation.

Beyond its primary role in cancer research, Nastorazepide's pharmacological profile suggests broader applications. Emerging research indicates its potential in managing pain, a common symptom associated with various chronic conditions and cancer. Furthermore, studies have hinted at its capability to inhibit the liver metastasis of colorectal cancer, pointing towards a multifaceted therapeutic potential that extends beyond its initial target indication. These diverse applications underscore the importance of Nastorazepide as a versatile research chemical and a potential pharmaceutical intermediate.

NINGBO INNO PHARMCHEM CO.,LTD. is proud to be a reliable source for high-purity Nastorazepide, supporting researchers worldwide in their endeavors to understand and harness its therapeutic capabilities. Whether exploring its anti-cancer effects, its role in pain modulation, or its anti-metastatic properties, access to quality Nastorazepide is paramount. Our commitment to rigorous quality control ensures that the Nastorazepide we supply meets the highest standards, enabling accurate and reproducible research outcomes. As scientific understanding of the CCK-2 receptor and its ligands continues to grow, Nastorazepide will undoubtedly remain a key compound in the pursuit of novel treatments.